希少皮膚疾患治療の世界市場2021年ー2031年:主要疾患別(全身性硬化症[強皮症]、表皮水疱症[EB]、尋常性天疱瘡、皮膚エリテマトーデス)、治療法別、流通チャネル別

• 英文タイトル:Rare Dermatological Disease Treatment Market (Major Indication: Systemic Sclerosis [Scleroderma], Epidermolysis Bullosa [EB], Pemphigus Vulgaris, and Cutaneous Lupus Erythematosus; Treatment: Corticosteroids, Immunosuppressants, Anti-inflammatory Agents, Antibiotics, Analgesics, and Others; and Distribution Channel: Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2031
• レポートコード:MRC2111A045
• 出版日:2021年8月18日